ISSN: 1837-9664Journal of Cancer
Global reach, higher impact
J Cancer 2023; 14(7):1157-1158. doi:10.7150/jca.85372 This issue Cite
Erratum
Cytochalasin H Inhibits Angiogenesis via the Suppression of HIF-1α Protein Accumulation and VEGF Expression through PI3K/AKT/P70S6K and ERK1/2 Signaling Pathways in Non-Small Cell Lung Cancer Cells: Erratum
Yuefan Ma1,2*, Zihan Xiu1,2*, Zhiyuan Zhou1,2, Bingyu Huang1,2, Jiao Liu1,2, Xiaofeng Wu1,2, Sanzhong Li1,2, Xudong Tang1,2,3,4 
1. Collaborative innovation center for antitumor active substance research and development, Guangdong Medical University, Zhanjiang 524023, P.R. China
2. Institute of Biochemistry and Molecular Biology, Guangdong Medical University, Zhanjiang 524023, P.R. China
3. Guangdong Key Laboratory for Research and Development of Natural Drugs, Guangdong Medical University, Zhanjiang 524023, P.R. China
4. Guangdong Provincial Key Laboratory of Medical Molecular Diagnostics, Guangdong Medical University, Dongguan 523808, P.R. China.
* These authors contribute equally to this work.
Corrected-article in J Cancer, Volume 10, 1997
In the original version of our article, “(Figure 2)” should be changed into “(Figure 3A)” in bottom line 7 of page 2002 (right). Moreover, there was an error in Figure 2F of the original version of our article. Specifically, the representative image of VEGF expression of H460 xenografted tumors in Figure 2F is incorrect. The correct image is provided below. This correction will not affect the results and conclusions. The authors apologize for any inconvenience this may have caused.
CyH inhibited angiogenesis in vivo and HIF-1α and VEGF protein expression in A549 and H460 NSCLC xenografts. A549 and H460 cells were treated with different concentrations (0, 6.25, 12.5, and 25 μM) of CyH. (A, B) Matrigel plugs. (C, D) The hemoglobin levels in Matrigel plugs. Hemoglobin content was expressed as (mg/g) of Matrigel plug. Immunohistochemical studies on the expression of HIF-1α and VEGF proteins in A549 (E) and H460 (F) xenografted tumors (original magnification, ×400). The results are representative of five independent experiments. Compared with control (lane 2), *P<0.05, **P<0.01.
Author contact
Corresponding author: Xudong Tang, MD, PhD, Collaborative innovation center for antitumor active substance research and development, Guangdong Medical University, 2 Wenming Donglu, Xiashan, Zhanjiang, Guangdong 524023, P.R. China. Phone: 86-759-2388581, Fax: 86-759-2284104, E-mail: tangxudong2599com, txdedu.cn.
Published 2023-4-28
Citation styles
